Recent developments in the use of chemotherapy in brain tumours.
about
Improving the extent of malignant glioma resection by dual intraoperative visualization approachO6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patientsNRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cellsGlioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.Chemotherapy alleviates subacute recurrent glioma-associated refractory cerebral edema by downregulating vascular endothelial growth factor.Prognostic and predictive biomarkers: tools in personalized oncology.Expression of delta-catenin is associated with progression of human astrocytoma.Surgical resection of malignant gliomas-role in optimizing patient outcome.Ruta graveolens L. induces death of glioblastoma cells and neural progenitors, but not of neurons, via ERK 1/2 and AKT activation.Glioblastoma treatment patterns, survival, and healthcare resource use in real-world clinical practice in the USA.Gene therapy for malignant glioma.Proteomic analysis of glioma chemoresistance.A new functional classification system (FGA/B) with prognostic value for glioma patients.Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo.Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma.S-alkylthiolation of O6-methylguanine-DNA-methyltransferase (MGMT) to sensitize cancer cells to anticancer therapy.Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels - A Strategy for Brain Cancer TreatmentsGene expression time-series analysis of camptothecin effects in U87-MG and DBTRG-05 glioblastoma cell lines.New developments in the treatment of malignant gliomas.Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization.Experience with irinotecan for the treatment of malignant gliomaIncreased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG.Insights into pharmacotherapy of malignant glioma in adults.Low-grade oligodendroglioma: current treatments and future hopes.A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics.KIAA0247 suppresses the proliferation, angiogenesis and promote apoptosis of human glioma through inactivation of the AKT and Stat3 signaling pathway.Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted?Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.Direct DNA methylation profiling using methyl binding domain proteinsInhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib.The effects of histone deacetylase inhibitors on glioblastoma-derived stem cells.Heterogeneity of human glioblastoma: glutathione-S-transferase and methylguanine-methyltransferase.Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age.Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours.Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison.Cytoprotective Effects of Cell-Permeable Bifunctional Antioxidant Enzyme, GST-TAT-SOD, against Cisplatin-Induced Cell Damage.Dynamic study of methionine positron emission tomography in patients with glioblastoma with oligodendroglial components.FRAT1 expression and its correlation with pathologic grade, proliferation, and apoptosis in human astrocytomas.Neuro-oncology: Glioblastoma--community adjusts to new standard of care.
P2860
Q21090866-1892270D-D5B7-4F00-831A-430C8CBF975EQ24607903-50394298-2B47-4BFD-8AF4-7B32916D7CF0Q29247923-6D33E1E4-C60B-4906-8D78-C7F8E749359FQ30275189-C6BA040A-EEAC-4048-B032-554FAE140229Q30448863-30155FAB-112D-4FEE-AA7E-ECC121548F40Q33415517-86486D51-4434-4BF5-932A-07EFA42A1288Q33651583-A7CA9EDC-42D2-42D5-AA5F-1C1480184ADFQ34029712-C6D111A7-1B94-46E4-8DFF-BEAA2FE70522Q34324963-A69DBE4D-0A79-44FE-AF52-CAFB1504F66BQ34668694-41568138-888B-4A19-BA64-8848E01B4707Q35222941-8B27197F-9DEF-4BFE-9DB6-064A630BF05BQ35673628-2A2F6D30-A31D-44F2-B6D8-A0237B250D7DQ35778723-0158014C-9E3A-429D-9CC9-E3788839098CQ36288720-5E60F802-1C34-4A32-ABBB-0688B0A810BCQ36291188-F3BA1F7E-9B81-44AE-B167-896DD5EAB9C7Q36610148-862FACC8-C2ED-4CE4-83B1-69FA89759444Q36734940-990DCD2D-F180-4D19-BB81-380C5EF29D71Q36764312-AFC91D67-B8B0-4A21-B7E8-E240B58BA633Q36916118-F4FCFC3E-8E52-4F2A-B49F-AB0D5178C88BQ36972696-1821B8F4-A1FC-4D86-BD29-CE4D16BCE597Q37185154-E57E971E-F60B-472C-81AA-9FBDB1307F75Q37265907-698F591E-52AA-45F6-9E7A-A93E0D1DF884Q37485784-DE7B3307-5C13-4B5B-9C7C-B5970368DE9DQ37575528-C1D3B437-4156-4471-89DA-419166003A5FQ37628706-8F25DD63-3D29-4576-97DE-83EDE106E04AQ37636717-BC0A42FB-CEAD-4C98-A442-A447BE32BA53Q37699378-8AAC5127-57E7-451A-BBC2-EA0449FD1622Q38074263-EFAB1A75-DA7B-49B7-825A-39B49E5FDC60Q38289553-202125ED-17F1-49D9-A321-2C2F8947ACA1Q38343730-D4ED0D45-D340-4D85-A8F4-CE6FFE8ECFB2Q38776733-BBC9E92F-8128-4CB6-9F52-C2D563FC227AQ38990450-AFF39472-5E97-4101-9877-E366A996F202Q39967654-089ADB86-ACFA-47DA-B052-3D80354E3E9DQ44293216-E4EF4561-1275-4E9D-A841-4B94EB2F1DF8Q46230407-BA817FB3-2909-4907-A1C2-C809D2793759Q48126047-9F692899-A60C-4542-86E1-F7B5DEAAE86DQ48247138-A0F0C077-B48A-4975-9D33-419C5DDE887EQ48261392-7DD0D7AB-D536-4D84-9878-7AE24483713AQ48365077-F895DA31-12EF-4215-867C-C9921A987D54Q48607482-2F731FBC-0E0E-4E5C-AAD5-3D2E765AE9A0
P2860
Recent developments in the use of chemotherapy in brain tumours.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Recent developments in the use of chemotherapy in brain tumours.
@ast
Recent developments in the use of chemotherapy in brain tumours.
@en
type
label
Recent developments in the use of chemotherapy in brain tumours.
@ast
Recent developments in the use of chemotherapy in brain tumours.
@en
prefLabel
Recent developments in the use of chemotherapy in brain tumours.
@ast
Recent developments in the use of chemotherapy in brain tumours.
@en
P1476
Recent developments in the use of chemotherapy in brain tumours
@en
P2093
Roger Stupp
P304
P356
10.1016/J.EJCA.2005.06.031
P577
2006-01-20T00:00:00Z